Physician profile
Ying-Ta Chen
NPI 1750533600
$4,305.87
in general payments reported to CMS, 2019-2025
17 companies · $662 in 2025
The $662 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $848 · 2021: $324 · 2022: $940 · 2023: $604 · 2024: $928 · 2025: $662.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Entertainment: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,908.77 |
| Entertainment | $284.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,045.32 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $582.60 | 2022-2025 | Infuse, Xiidra, Miebo |
| Alcon Vision LLC | $376.82 | 2019-2025 | Precision7 |
| Sun Pharmaceutical Industries INC. | $356.16 | 2022-2024 | Cequa |
| Optos, INC. | $328.17 | 2019-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $309.29 | 2024-2025 | Misight Contact Lens, Synergeyes Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $238.53 | 2019 | |
| Rxsight INC | $145.30 | 2022-2024 | Rxsight Injector Handpiece, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Kala Pharmaceuticals, INC. | $123.00 | 2021 | |
| Dompe US, INC. | $121.81 | 2023 | Oxervate |
| Harrow Eye, LLC | $113.51 | 2025 | Vevye |
| Shire North American Group INC | $113.22 | 2019 | |
| Sight Sciences, INC. | $111.75 | 2024 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $110.36 | 2025 | Xdemvy |
| Eyevance Pharmaceuticals LLC | $94.06 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $92.32 | 2024 | |
| Carl Zeiss Meditec, INC. | $43.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ying-Ta Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.